GE HealthCare Techs Q1 2024 Adj EPS $0.90 Misses $0.91 Estimate, Sales $4.650B Miss $4.801B Estimate
Portfolio Pulse from Benzinga Newsdesk
GE HealthCare Techs (GEHC) reported Q1 2024 adjusted EPS of $0.90, missing the $0.91 estimate, and sales of $4.650B, below the $4.801B estimate. This represents a 5.88% increase in EPS and a 1.21% decrease in sales from the same period last year.
April 30, 2024 | 10:21 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GE HealthCare Techs reported a slight miss in Q1 2024 earnings and sales compared to analyst estimates, with a minor increase in EPS and a decrease in sales from the previous year.
The miss in both earnings per share and sales estimates, despite being slight, could lead to short-term negative sentiment among investors. The year-over-year growth in EPS might not fully offset the disappointment from not meeting expectations, especially in a market that values consistent performance and growth. The decrease in sales compared to the previous year further compounds concerns about the company's revenue growth trajectory.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100